This offering is a near-term liquidity necessity from a distressed issuer with a going concern warning. The $0.30 price is a 93% discount to the $4.00 IPO price last September. Post-offering, the company remains undercapitalized with $15M secured note and missed payments. Expect continued volatility and potential further dilution from warrant exercises.
Executive Summary
Picard Medical priced a best-efforts offering of 16.7M common shares and warrants at $0.30/unit, raising $5M gross ($3.08M net). The proceeds will fund R&D, working capital, and debt repayment, but the company faces severe financial distress with a $27M net loss in 2025, a going concern opinion, and a cash burn that requires this dilutive capital.
Key Financial Metrics
Key Facts
- Offering of 16,666,667 shares of common stock and accompanying Series A and B warrants at $0.30 per unit
- Gross proceeds of $5.0 million; net proceeds ~$3.08 million after fees and expenses
- Pro forma shares outstanding increase from 75.4M to 92.0M (22.1% dilution), excluding warrants
- WestPark Capital is the placement agent with 7% cash fee
- Directors and officers subject to 30-day lock-up
- Auditor included going concern opinion for fiscal year 2025
- Net loss of $27.0 million in 2025 vs $21.1 million in 2024
- Revenue grew 13% but gross loss widened to $0.2 million
- Company has missed April and May 2026 redemption payments on senior secured note
Financial Impact
Gross proceeds $5.0M, net ~$3.08M; 22.1% dilution to existing shareholders from common shares alone
Risk Factors
- Significant dilution to existing shareholders
- Going concern risk persists despite offering
- Missed debt redemption payments signal financial strain
- Low offering price reflects deep distress and potential for further capital needs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B4 Filing (Primary) | 0001829126-26-004627 |
| Document: 0001829126-26-004627-index-headers.html | 0001829126-26-004627 |
| Document: 0001829126-26-004627-index.html | 0001829126-26-004627 |
| Document: 0001829126-26-004627.txt | 0001829126-26-004627 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $7.09 | awaiting T+60 | — | $6.68 (−5.85%) |
Oct 22, 2026 4d ago | S-3 | $7.37 | awaiting T+60 | — | $6.68 (+9.43%) |
Oct 6, 2026 20d ago | 8-K | $8.74 | awaiting T+60 | — | $6.68 (+23.63%) |
Jul 27, 2026 13w ago | 8-K | $0.0878 $0.2096 | ▲ +138.72% | ▲ +134.67% | $6.68 (+7502.51%) |
Jul 15, 2026 14w ago | DEFA14A | $0.1600 $0.1896 | ▲ +18.50% | ▲ +14.79% | $6.68 (+4071.88%) |
Jul 8, 2026 15w ago | DEFA14A | $0.1500 $0.0864 | ▼ −42.40% | ▼ −44.89% | $6.68 (+4350.00%) |
Jul 2, 2026 16w ago | 8-K / 425 | $0.1694 | awaiting T+60 | — | $6.68 (+3840.38%) |
Jun 29, 2026 17w ago | 8-K | $0.1559 $0.0910 | ▼ −41.63% | ▼ −45.25% | $6.68 (+4181.59%) |
Jun 2, 2026 21w ago | Press Release | $13.50 | awaiting T+60 | — | $6.68 (−50.56%) |
Jun 2, 2026 21w ago | 8-K | $13.50 | awaiting T+60 | — | $6.68 (+50.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers